Longevity Science in [2026]: 5 Interventions With Real Evidence

Longevity science has gone from academic backwater to one of the most lavishly funded and intensely marketed areas of biomedicine. Silicon Valley billionaires fund longevity research and take dozens of supplements daily. Clinics selling "longevity protocols" charge thousands per month. The question of how much of this reflects genuine scientific progress and how much is wishful thinking monetized has become important enough to engage with honestly. Here is where the evidence actually stands.

What Longevity Science Is Actually Trying to Do

The longevity research field has two distinct goals that are often conflated: extending maximum lifespan (how long the longest-lived humans can live) and extending healthspan (the period of life spent in good health). Most serious researchers and, I'd argue, most people actually care primarily about the second. Living to 120 while spending the last 30 years in cognitive and physical decline is not obviously desirable. Living to 90 in good health is.

The biological hallmarks of aging — the cellular and molecular processes that drive age-related decline — have been substantially mapped over the past two decades. The 2013 paper by Lopez-Otin identifying nine hallmarks of aging (including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, and several others) provided a framework that the field has substantially built on. Understanding these mechanisms has produced a pipeline of potential interventions, most of which are still in early research or clinical trial stages.

What the Evidence Actually Supports

The interventions with the strongest evidence for extending healthy lifespan in humans are, unfortunately for those hoping for supplement shortcuts, the familiar ones. Regular physical activity — particularly a combination of resistance training and cardiovascular exercise — has the most consistent and robust association with longevity outcomes of any modifiable factor studied. The effect is large: physically active people live measurably longer with substantially better physical function in later decades. Not metaphorically better — literally more years and more functional years.

Caloric restriction — reducing calorie intake without malnutrition — extends lifespan in essentially every organism where it's been tested, from yeast to mice. Whether it meaningfully extends human lifespan (as opposed to improving healthspan markers) is less certain, because the human studies are shorter than a lifespan and the adherence challenges are enormous. The CALERIE trial showed that modest caloric restriction (15% reduction) in healthy adults improved metabolic health markers significantly. The CALERIE 2 findings published in Nature Aging in 2022 showed reduced inflammatory markers and thymic fat involution (a measure of immune aging) in the caloric restriction group.

Sleep is the longevity intervention with the clearest dose-response relationship for mortality risk. Both short sleep (under 6 hours) and long sleep (over 9 hours) are associated with increased all-cause mortality in large epidemiological studies. The 7-9 hour range shows the lowest mortality risk. This is an association, not proven causation, but it's consistent across populations and time periods.

The Supplement Situation

The longevity supplement market is enormous and mostly ahead of the evidence. The most prominent supplements in the longevity space: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) work as NAD+ precursors — raising NAD+ levels, which decline with age and are involved in multiple cellular repair processes. Animal studies are promising. Human clinical trials show that NMN and NR do raise NAD+ levels. Whether raising NAD+ levels in humans produces meaningful longevity or healthspan benefits has not been demonstrated in human trials with longevity endpoints — the trials are too short. The supplement is plausible; the evidence for humans doesn't yet support the confidence of the marketing.

Rapamycin — an FDA-approved immunosuppressant — is the longevity intervention with the most impressive animal data. It extends lifespan in mice by 10-25% even when started in middle age. Multiple longevity researchers are taking low-dose rapamycin off-label for longevity purposes. Human clinical trials (PEARL study and others) are ongoing. The potential benefit is real; the side effect profile (immunosuppression, potential for metabolic effects) means this is not a supplement to take without medical supervision and a clear-eyed view of the risk-benefit calculation for a healthy person.

GLP-1 drugs, metformin, and senolytics (compounds that clear senescent "zombie" cells) are all in various stages of human clinical investigation for longevity applications. These are prescription medications being studied for new indications — not supplements — and their longevity applications are genuinely promising research areas rather than established treatments.

The Biological Age Testing Trend

Epigenetic clocks — tests that estimate biological age from DNA methylation patterns — have become commercial products marketed as ways to measure whether your lifestyle choices are slowing aging. The science behind epigenetic clocks is genuine: Horvath's clock and subsequent iterations do correlate with health outcomes and all-cause mortality. Whether the commercial tests provide information that's actionable and accurate enough to justify the cost ($300-600 for most tests), and whether improving your clock score through interventions actually improves longevity outcomes rather than just moving the clock number, are questions the evidence doesn't fully answer yet.

My take: Exercise and sleep are the longevity interventions with the strongest evidence and no downsides. Caloric restriction has good mechanistic support. Most longevity supplements are plausible but ahead of the human evidence. Rapamycin is the most interesting pharmacological candidate but requires medical supervision. The industry's marketing confidence is significantly ahead of the science's certainty.